147 related articles for article (PubMed ID: 127560)
1. Antagonism of d-lysergic acid diethylamide and mescaline by 1-methyl-1, 2, 5, 6-tetrahydropyridine-N, N-diethyl-carboxamide (THPC).
Dyer DC; Benington F; Morin RD
Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):197-200. PubMed ID: 127560
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
Dyer DC
J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
[No Abstract] [Full Text] [Related]
3. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
Colpaert FC; Niemegeers CJ; Janssen PA
J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
[No Abstract] [Full Text] [Related]
4. Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl- carboxamide.
Christian ST; McClain LD; Morin RD; Benington F
Experientia; 1975 Aug; 31(8):910-11. PubMed ID: 125655
[No Abstract] [Full Text] [Related]
5. Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature.
Dyer DC; Gant DW
J Pharmacol Exp Ther; 1973 Feb; 184(2):366-75. PubMed ID: 4347258
[No Abstract] [Full Text] [Related]
6. Contractile responses of guinea pig umbilical arteries to various hallucinogenic agents.
Nair X
Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):535-42. PubMed ID: 4445570
[No Abstract] [Full Text] [Related]
7. The pharmacology of isolated sheep umbilical cord blood vessels.
Dyer DC
J Pharmacol Exp Ther; 1970 Dec; 175(3):565-70. PubMed ID: 4395224
[No Abstract] [Full Text] [Related]
8. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
Burris KD; Sanders-Bush E
Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
[TBL] [Abstract][Full Text] [Related]
9. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
Callahan PM; Appel JB
J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
[TBL] [Abstract][Full Text] [Related]
10. Lysergic acid diethylamide is a partial agonist at 5-HT2 receptors in ovine uterine artery of late pregnancy.
Zhang L; Dyer DC
Eur J Pharmacol; 1993 Jan; 230(1):115-7. PubMed ID: 8428600
[TBL] [Abstract][Full Text] [Related]
11. Phencyclidine, lysergic acid diethylamide, and mescaline: cerebral artery spasms and hallucinogenic activity.
Altura BT; Altura BM
Science; 1981 May; 212(4498):1051-2. PubMed ID: 7195070
[TBL] [Abstract][Full Text] [Related]
12. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
Schechter MD; Winter JC
J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
[No Abstract] [Full Text] [Related]
13. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
Schoenfeld RI
Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
[TBL] [Abstract][Full Text] [Related]
14. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD).
KOELLE GB
N Engl J Med; 1958 Jan; 258(1):25-32. PubMed ID: 13493730
[No Abstract] [Full Text] [Related]
15. Differential antagonism by metergoline of the behavioral effects of indolealkylamine and phenethylamine hallucinogens in the rat.
Commissaris RL; Lyness WH; Moore KE; Rech RH
J Pharmacol Exp Ther; 1981 Oct; 219(1):170-4. PubMed ID: 6793709
[No Abstract] [Full Text] [Related]
16. Double bonds, aliphatic chains, and hallucinogens, updated.
Abramson HA; Gettner HH
J Asthma Res; 1979 Jul; 16(4):120. PubMed ID: 391793
[No Abstract] [Full Text] [Related]
17. Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.
Fischer R; Goldman H
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):176-84. PubMed ID: 1233520
[TBL] [Abstract][Full Text] [Related]
18. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
Mokler DJ; Commissaris RL; Warner MR; Rech RH
J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
